Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating oral isotretinoin versus standard of care for moderate acne in skin of color patients, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Acne Vulgaris | Phase 3 | Status: RECRUITING